Sartorius 2Q Net Profit Fell on Sales Hit From Weaker Demand
21 Juli 2023 - 7:44AM
Dow Jones News
By Adria Calatayud
Sartorius said Friday that second-quarter net profit fell on
sales that took a hit from weaker demand in both its bioprocess and
laboratory-products divisions, and confirmed its recently
downgraded outlook for 2023.
The German life-sciences group said net profit for the second
quarter was 95.0 million euros ($105.7 million) compared with
EUR165.8 million in the year-earlier period.
Revenue for the quarter dropped to EUR832.0 million from EUR1.04
billion a year before, with a 19% fall in bioprocess solutions and
a 13% decline in lab products and services. Order intake for the
quarter was down by a third at EUR684.8 million.
Sartorius's quarterly underlying earnings before interest,
taxes, depreciation and amortization fell 30% to EUR244.7
million.
The company said its outlook for the year remains unchanged
after it issued a profit warning last month, citing a postpandemic
slump in demand.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
July 21, 2023 01:29 ET (05:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Sartorius (TG:SRT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Sartorius (TG:SRT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024